Schedule 13G ownership disclosure

OUTLOOK THERAPEUTICS INC

Common Stock, par value $0.01 per share · CUSIP: 69012T305

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • TANG CAPITAL MANAGEMENT, LLC

    Shares: 1,500,000.00 · Class: 3.4%

  • KEVIN TANG

    Shares: 1,500,000.00 · Class: 3.4%

  • TANG CAPITAL PARTNERS, LP

    Shares: 1,500,000.00 · Class: 3.4%

  • TANG CAPITAL PARTNERS INTERNATIONAL, LP

    Shares: 0.00 · Class: 0%

  • TANG CAPITAL PARTNERS III, INC

    Shares: 0.00 · Class: 0%

  • TANG CAPITAL PARTNERS IV, INC

    Shares: 0.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-25-012269
Form type
SCHEDULE 13G/A
Filer
Outlook Therapeutics, Inc.
CIK
CIK 1649989
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub